Bristol-Myers Squibb Co (NYSE:BMY)

61.48
Delayed Data
As of Sep 18
 +0.18 / +0.29%
Today’s Change
49.96
Today|||52-Week Range
70.05
+0.33%
Year-to-Date
Aduro's Cancer Arm & Strong Collaborations Boost Growth
Sep 18 / Zacks.com - Paid Partner Content
Bristol-Myers Squibb's New Psoriasis Drug Has Echoes of Humira
Sep 16 / GuruFocus News - Paid Partner Content
Bayer (BAYRY) Focuses on Acquisitions, Competition a Concern
Sep 18 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: AZN's Leukemia Drug Wins FDA Nod, MRK's Keytruda in Focus
Sep 14 / Zacks.com - Paid Partner Content
Cytori's Chemotherapy Candidate Gets Orphan Drug Status
Sep 18 / Zacks.com - Paid Partner Content
Roche's Child Arthritis Drug's New Formulation Gets FDA Nod
Sep 14 / Zacks.com - Paid Partner Content
Can Pfizer (PFE) Bank on Bavencio for Long-Term Growth?
Sep 18 / Zacks.com - Paid Partner Content
Immunotherapy for NSCLC: 4 Large-Cap Pharma Stocks in Focus
Sep 12 / Zacks.com - Paid Partner Content
'The New Buffettology': Finding Durable Competitive Advantages
Sep 17 / GuruFocus News - Paid Partner Content
Bristol-Myers (BMY) Reports Phase II Data on Psoriasis Drug
Sep 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close61.30
Today’s open61.18
Day’s range61.13 - 61.66
Volume3,703,572
Average volume (3 months)6,172,726
Market cap$100.0B
Data as of 4:00pm ET, 09/18/2018

Growth & Valuation

Earnings growth (last year)-76.98%
Earnings growth (this year)+19.56%
Earnings growth (next 5 years)+11.70%
Revenue growth (last year)+6.94%
P/E ratio256.2
Price/Sales4.87
Price/Book8.48

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.42+1.07%
AZNAstraZeneca-0.07-0.19%
SNYSanofi+0.21+0.48%
NVONovo Nordisk-0.21-0.44%
Data as of 4:03pm ET, 09/18/2018

Financials

Next reporting dateOctober 25, 2018
EPS forecast (this quarter)$0.89
Annual revenue (last year)$20.8B
Annual profit (last year)$1.0B
Net profit margin4.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Giovanni Caforio
CFO, EVP &
Head-Global Business Operations
Charles A. Bancroft
Corporate headquarters
New York, New York

Forecasts